Citation

Konteatis Z, Travins J, Gross S, Marjon K, Barnett A, Mandley E, Nicolay B, Nagaraja R, Chen Y, Sun Y, Liu Z, Yu J, Ye Z, Jiang F, Wei W, Fang C, Gao Y, Kalev P, Hyer ML, DeLaBarre B, Jin L, Padyana AK, Dang L, Murtie J, Biller SA, Sui Z, Marks KM.: Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous <i>MTAP</i> Deletion. J Med Chem, Volume 64 (8), 2021

Authors

Barnett A, Biller SA, Chen Y, Dang L, DeLaBarre B, Fang C, Gao Y, Gross S, Hyer ML, Jiang F, Jin L, Kalev P, Konteatis Z, Liu Z, Mandley E, Marjon K, Marks KM., Murtie J, Nagaraja R, Nicolay B, Padyana AK, Sui Z, Sun Y, Travins J, Wei W, Ye Z, Yu J

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.0c01895

PubMed

33829783

Machine-readable

REST APIRDF